Kidney cancer: open trials in Czechia

• NCT07011719

  Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

  Trial Treatment · Phase 3 · Arcus Biosciences, Inc.

  Fakultni nemocnice Brno, Brno · Masarykuv Onkologicky Ustav, Brno-Stred · Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · Nemocnice České Budějovice, a.s., České Budějovice · Fakultni nemocnice Hradec Kralove, Hradec Králové · University Hospital Olomouc, Olomouc · Fakultni nemocnice Kralovske Vinohrady, Prague · Fakultni Nemocnice Motol a Homolka, Prague · Fakultni Thomayerova nemocnice, Prague · Fakultni nemocnice Bulovka, Prague

  Registry updated 2026-11-02

• NCT07489495

  A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Masarykuv Onkologicky Ustav, Brno-Stred · Fakultni nemocnice Hradec Kralove, Hradec Králové · University Hospital Olomouc, Olomouc · Fakultni nemocnice Ostrava, Ostrava · Fakultni nemocnice v Motole, Prague · Vseobecna Fakultni Nemocnice V Praze, Prague 2

  Registry updated 2026-10-29

• NCT07293351

  A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

  Trial Treatment · Phase 1/2 · Bristol-Myers Squibb

  Masarykuv Onkologicky Ustav, Brno-Stred · Fakultni nemocnice Hradec Kralove, Hradec Králové · Fakultni Nemocnice Motol a Homolka, Prague

  Registry updated 2026-10-23

• 2025-524160-38-00

  A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Masarykuv Onkologicky Ustav, Brno-Stred · Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · University Hospital Olomouc, Olomouc · Fakultni Thomayerova nemocnice, Prague

  Registry updated 2026-10-01

• 2023-503317-29-00

  CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

  Trial Treatment · Phase 3 · Institut Gustave Roussy

  Masarykuv Onkologicky Ustav, Brno-Stred · Fakultni Nemocnice Hradec Kralove, Novy Hradec Kralove · University Hospital Olomouc, Olomouc · Fakultni Nemocnice Plzen, Plzen 23 · Fakultni nemocnice v Motole, Prague

  Registry updated 2026-09-28

• NCT07227402

  A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Masarykuv Onkologicky Ustav, Brno-Stred · Nemocnice České Budějovice, a.s., České Budějovice · Fakultni nemocnice Hradec Kralove, Hradec Králové · University Hospital Olomouc, Olomouc · Fakultni nemocnice Ostrava, Ostrava · Fakultni Nemocnice Motol a Homolka, Prague · Vseobecna Fakultni Nemocnice V Praze, Prague 2

  Registry updated 2026-08-03

• NCT06364631

  CARE1 Pragmatic Clinical Trial

  Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris

  Masarykův onkologický ústav, Masaryk Memorial Cancer Institute (MOU), Brno · Fakultní nemocnice Hradec Králová, University Hospital Hradec Kralove (FNHK), Hradec Králové · Fakultní nemocnice Olomouc, University Hospital Olomouc (FNOL), Olomouc · Fakultní nemocnice v Motole, University Hospital Motol (MOTOL), Prague

  Registry updated 2025-01-16

All Kidney cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error